Veristat Acquires Biometrics-focused Instat Clinical Research
Veristat, a scientific full-service clinical research organization (CRO) and consultancy, has acquired Instat Clinical Research, an expert biometrics CRO with a 20-year track record of transforming complex data into precise study results.
The acquisition strengthens Veristat’s expertise and solutions in biometrics, one of the most impactful activities in the clinical research workflow. Instat brings complementary proficiencies to Veristat’s global data management, biostatistics, and statistical programming teams, with staff located in the United States and India. Instat has extensive experience partnering with clients to optimize how clinical studies are designed and how data is collected, integrated, and analyzed to meet the requirements of global regulatory organizations across the United States, Europe, and Asia. The addition of the India location complements Veristat’s existing facility in Taipei, offering clients access to a round-the-clock team to contribute timely data and accelerate drug development cycle times.
“Our clients must be able to understand and quickly act on the insights gleaned from their study data in both the trial design and trial execution stages of their programs,” said Patrick Flanagan, Chief Executive Officer of Veristat. “Instat brings a proven track record having supported over 100 sponsor-led clinical studies, authoring over 150 statistical analysis plans, and participating in over 30 regulatory submissions. The addition of Instat’s seasoned talent will further strengthen our ability to help clients bring their drugs and biologics to market faster.”
Both Veristat’s and Instat’s biometrics teams have significant expertise in statistical consulting, clinical data programming, statistical analysis, data management, and project management, supporting the development of complex biologic and drug therapies to treat rare cancers, central nervous system/neurological disorders, endocrine/metabolic disorders, and infectious diseases as well as various other therapeutic areas.
“As biotherapeutics continue to evolve, so does biometrics, the unequivocal underpinning of clinical research,” stated Kyle McBride, CEO and Co-founder of Instat. “Instat possesses the ideal mix of talent, technical acumen, and technology solutions to keep pace with this change and bring statistical understanding across the clinical development lifecycle. On behalf of the entire Instat team, we are thrilled to begin our next chapter with Veristat. Our joining allows us to offer world-class end-to-end services to our clients while acting with the speed and effectiveness our customers have come to rely on.”
More information on Veristat’s biometrics services can be found at https://www.veristat.com/services/biometrics
About Veristat
Veristat is a scientific full-service clinical research organization (CRO) and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies. We collaborate with our clients to support the rapid delivery of their life-changing therapies, helping them make sound decisions amidst uncertainties. Our scientific experts design and conduct the global activities required for any clinical, regulatory, or commercialization program comprehensively and efficiently.
With our focus on novel drug development and nearly 30 years of experience, our versatile approach and bold scientific thinking make the impossible possible. Clients depend on our game-changing expertise and reliable execution for fast results and positive impact to support their biologics and drugs to treat rare cancers, CNS/neurological disorders, endocrine/metabolic disorders, and infectious diseases. We are…Bold. Scientific. Versatile. Veristat.
About Instat
Since its inception in 2003, Instat has served as a trusted partner to clients in the pharmaceutical, biotechnology, and medical device industries, seamlessly integrating its reliable team of experts to produce quality deliverables and innovative solutions. Instat provides comprehensive biometric (data management and statistical) services for all phases of clinical drug development.
With an average of 27 years of industry experience among senior leadership, Instat experts possess the hands-on expertise to design studies and inform regulatory documents to support clients’ global drug submissions and approvals. It is Instat’s goal that new products will make it to market and into the hands of those striving for healthier lives. This goal begins with a client’s drug development, and when partnered with Instat’s analytical expertise, progress is made together to support a healthier future.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231019356952/en/
Contact information
Lauren L. Brennan, Vice President of Marketing, Veristat
media@veristat.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Dubai Electricity and Water Authority PJSC Reports a Record AED 14.6 Billion in Revenue for the First Half of 2025 and Approves Dividend Payment of AED 3.1 Billion8.8.2025 18:47:00 EEST | Press release
Dubai Electricity and Water Authority PJSC (ISIN: AED001801011) (Symbol: DEWA), Dubai’s exclusive electricity and water services provider, which is listed on the Dubai Financial Market (DFM), today reported its first half 2025 consolidated financial results, recording first half revenue of AED 14.6 billion, EBITDA of AED 7.0 billion, operating profit of AED 3.7 billion, net profit of AED 2.9 billion and cash from operations of AED 9.2 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250808832927/en/ Dubai Electricity and Water Authority PJSC reports a record AED 14.6 billion in revenue for the first half of 2025 and approves dividend payment of AED 3.1 billion (Graphic: AETOSWire) “DEWA is committed to be an innovative and sustainable corporation inspired by the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the directives of His Highn
Philippine Government and Sutherland Launch AI Academy to Equip Filipinos with Future-Ready Skills8.8.2025 16:54:00 EEST | Press release
Sutherland, a global leader in business and digital transformation, has partnered with the Philippine Government to launch a dedicated AI Academy. This strategic initiative supports the Philippine government’s broader efforts to empower the Filipino workforce for an AI-driven future. The AI Academy will offer practical, industry-aligned training designed to equip Filipino professionals with skills to integrate artificial intelligence into their work. It aims to strengthen the country’s talent pool by developing capabilities that are increasingly in demand across sectors, whether as AI specialists, prompt engineers, or cybersecurity professionals. The program will prepare participants to harness AI in driving productivity, advancing innovation, and pursuing high-value opportunities across industries. “This initiative is a vital step toward our goal of building a digitally resilient and inclusive workforce, said President Ferdinand R. Marcos Jr. “By expanding access to training in future
Baraja Appoints IP Pioneer to Lead Global Sale of Spectrum-Scan™ LiDAR IP Assets8.8.2025 16:00:00 EEST | Press release
Baraja Pty Ltd (“Baraja”), the Australian pioneer behind the revolutionary Spectrum‑Scan™ LiDAR architecture, has announced a global initiative to commercialize its full suite of patented LiDAR intellectual property and technical assets. The company has appointed IP Pioneer Group Incas the exclusive worldwide advisor to manage this competitive transaction process. Baraja redefined LiDAR performance through its Spectrum-Scan™ technology—a transformative solid-state architecture that steers the laser beam by tuning its wavelength through a dispersive prism or grating, eliminating moving parts. This breakthrough enables long-range, high-resolution 3D sensing that is inherently immune to alignment drift, sunlight, and multi-LiDAR interference. Having achieved significant technical milestones in LiDAR innovation, Baraja is now strategically evolving its business focus to pursue new frontiers in sensing and perception. This initiative will allow a new commercial partner to capitalize on the
Graanul - Expiry of Early Consent Deadline relating to the Consent Solicitation and Scheme Solicitation8.8.2025 13:54:00 EEST | Press release
Graanul: Expiry of Early Consent Deadline relating to the Consent Solicitation and Scheme Solicitation for Graanul’s: €250,000,000 Floating Rate Sustainability-Linked Senior Secured Notes due 2026 (Regulation S Notes: ISIN Number XS2397354015 / Common Code 239735401 Rule 144A Notes: ISIN Number XS2397354288 / Common Code 239735428) (the “Existing Floating Rate Notes”) and €380,000,000 4.625% Sustainability-Linked Senior Secured Notes due 2026 (Regulation S Notes: ISIN Number XS2397354528 / Common Code 239735452 Rule 144A Notes: ISIN Number: XS2397355095 / Common Code 239735509) (the “Existing Fixed Rate Notes” and, together with the Existing Floating Rate Notes, the “Existing Notes”) of Cullinan Holdco SCSp a special limited partnership (société en commandite spéciale) established under the laws of Luxembourg, having its registered office at 2, avenue Charles de Gaulle, L-1653, registered with the Luxembourg Register of Commerce and Companies under number B-256979 (the “Issuer” and tog
Traka Celebrates 30 Years of Innovation in Intelligent Key and Asset Management8.8.2025 12:00:00 EEST | Press release
Traka, an ASSA ABLOY company and global leader in intelligent key and equipment management solutions, is excited to announce its 30 years of innovation in intelligent key and asset management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250808492250/en/ Traka is celebrating its 30th anniversary this year after its inception in 1995. What began as a custom solution for British Airways has grown into a global leader in intelligent key and asset management. Traka, now celebrating its 30th anniversary, is marking three decades of innovation, expansion, and impact across more than 30 industries worldwide. In 1995, Traka’s founder, John Kent, responded to a unique challenge: British Airways needed a secure and trackable way to manage critical keys, something the market didn’t yet offer. Kent built the first Traka key cabinet, setting the foundation for what would become a new category in access management. That first electronic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom